• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-45
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage, Cerebral (1889); Weakness (2145); Confusion/ Disorientation (2553); No Code Available (3191)
Event Date 06/16/2020
Event Type  Injury  
Event Description
It was reported that during a permanent implant procedure the patient became confused and experienced weakness on the right side.This occurred after the first lead was successfully implanted in the left hemisphere and the staff was setting up to implant a second lead in the right hemisphere.The time between the lead implant and onset of symptoms was within minutes.The procedure was aborted and the physician noted that an intracranial hemorrhage occurred in the basal ganglia along the left sided planned trajectory.Vasculature was not detected on the magnetic resonance imaging.The physician chose to leave the lead on the left hemisphere implanted as well as the burr hole covers.The event was not a result of device performance.The patient was brought to the intensive care unit and the hemorrhage was evacuated.Three days later the patient returned to surgery due to relieve pressure and symptoms caused by the intracranial hemorrhage.During the same surgery the physician explanted the left hemisphere lead.The patient was released from the hospital with what could turn out to be a permanent tracheostomy as he is not able to breath on his own.The patient does not have a good prognosis.The explanted devices were discarded and will not be returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
RQ   00646-2602
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key10268290
MDR Text Key198697777
Report Number3006630150-2020-02892
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905288
UDI-Public08714729905288
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/26/2022
Device Model NumberDB-2202-45
Device Catalogue NumberDB-2202-45
Device Lot Number7073985
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/16/2020
Initial Date FDA Received07/13/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/26/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age53 YR
-
-